← All trials
NCT06139029
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2022
- Primary completion
- Mar 15, 2023
- Completion date
- Mar 15, 2023
- First posted
- Nov 18, 2023
- Last posted
- Nov 21, 2023
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mardan Medical ComplexLead sponsor
- Mardan Medical ComplexOverall official - principal investigator
- Mardan Medical ComplexReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.